An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 1, 2008, Pages 97.e1-97.e6

  Swidsinski, Alexander ^a   Mendling, Werner ^d   Loening Baucke, Vera ^a   Swidsinski, Sonja ^e   Dörffel, Yvonne ^b   Scholze, Jürgen ^b   Lochs, Herbert ^c   Verstraelen, Hans ^f  

^a Molekulargenetisches Labor für polymikrobielle Infektionen und bakterielle Biofilme   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Vivantes Kliniken für Gynäkologie und Geburtsmedizin am Urban und im Friedrichshain   (Germany)

^e KAU Berlin   (Germany)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

Antibiotic resistance; bacterial biofilm; bacterial vaginosis; Gardnerella vaginalis; metronidazole

Indexed keywords

DNA 16S; DNA 23S; METRONIDAZOLE; RECOMBINANT DNA;

ADULT; ARTICLE; ATOPOBIUM VAGINAE; BACTERIUM ADHERENCE; BIOFILM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GARDNERELLA VAGINALIS; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT DURATION; VAGINA EPITHELIUM; VAGINA FLORA; VAGINA MUCOSA; VAGINITIS;

EID: 37349022421     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.06.039     Document Type: Article

References (32)

1. Sobel J.D. Bacterial vaginosis. Annu Rev Med 51 (2000) 349-356
2. Wiesenfeld H.C., Hillier S.L., Krohn M.A., Landers D.V., and Sweet R.L. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 36 (2003) 663-668
3. Cherpes T.L., Meyn L.A., Krohn M.A., Lurie J.G., and Hillier S.L. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis 37 (2003) 319-325
4. Schwebke J.R. Gynecologic consequences of bacterial vaginosis. Obstet Gynecol Clin North Am 30 (2003) 685-694
5. Cu-Uvin S., Hogan J.W., Caliendo A.M., et al. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 33 (2001) 894-896
6. Cohn J.A., Hashemi F.B., Camarca M., et al. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. J Acquir Immune Defic Syndr 39 (2005) 340-346
7. Sha B.E., Zariffard M.R., Wang Q.J., et al. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 191 (2005) 25-32
8. Cherpes T.L., Melan M.A., Kant J.A., Cosentino L.A., Meyn L.A., and Hillier S.L. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B streptococcus colonization. Clin Infect Dis 40 (2005) 1422-1428
9. Schwebke J.R. Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases. J Infect Dis 192 (2005) 1315-1317
10. Centers for Disease Control and Prevention, Workowski K.A., and Berman S.M. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 55 (2006) 1-94
11. Larsson P.G., and Forsum U. Bacterial vaginosis: a disturbed bacterial flora and treatment enigma. APMIS 113 (2005) 305-316
12. Swidsinski A., Mendling W., Loening-Baucke V., et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106 (2005) 1013-1023
13. Tool G.O., Kaplan H.B., and Kolter R. Biofilm formation as microbial development. Ann Rev Microbiol 54 (2000) 49-79
14. Costerton W., Veeh R., Shirtliff M., et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112 (2003) 1466-1477
15. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
16. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29 (1991) 297-301
17. Swidsinski A. Standards for bacterial identification by fluorescence in situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes. Inflamm Bowel Dis 12 (2006) 824-826
18. Harmsen H.J., Wildeboer-Veloo A.C., Grijpstra J., Knol J., Degener J.E., and Welling G.W. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 66 (2000) 4523-4527
19. Harmsen H.J., Elfferich P., Schut F., and Welling G.W. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in fecal samples by fluorescent in situ hybridization. Microbiol Ecol Health Dis 11 (1999) 3-12
20. Manz W., Amann R., Ludwig W., Vancanneyt M., and Schleifer K.H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-Flavobacter-Bacteroides in the natural environment. Microbiology 142 (1996) 1097-1106
21. Poulsen L.K., Licht T.R., Rang C., Krogfelt K.A., and Molin S. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 177 (1995) 5840-5845
22. Amann R., Krumholz L., and Stahl D.A. Fluorescent-oligonucleotide probing of whole cells for determinative, phylogenetic, and environmental studies in microbiology. J Bacteriol 172 (1990) 762-770
23. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., and Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43 (2005) 3380-3389
24. van der Meijden W.I., Koerten H., van Mourik W., and de Bruijn W.C. Descriptive light and electron microscopy of normal and clue-cell-positive discharge. Gynecol Obstet Invest 25 (1988) 47-57
25. Scott T.G., Curran B., and Smyth C.J. Electron microscopy of adhesive interactions between Gardnerella vaginalis and vaginal epithelial cells, McCoy cells and human red blood cells. J Gen Microbiol 135 (1989) 475-480
26. Bannatyne R.M., and Smith A.M. Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis. Sex Transm Infect 74 (1998) 455-456
27. Aroutcheva A.A., Simones J.A., Behbakht K., and Faro S. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin Infect Dis 33 (2001) 1022-1027
28. Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., and Hillier S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191 (2004) 1124-1129
29. Simoes J.A., Aroutcheva A.A., Shott S., and Faro S. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol 9 (2001) 41-45
30. Agnew K.J., and Hillier S.L. The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis 22 (1995) 269-273
31. Ferris M.J., Masztal A., Aldridge K.E., Fortenberry J.D., Fidel Jr. P.L., and Martin D.H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4 (2004) 5
32. Bradshaw C.S., Tabrizi S.N., Fairley C.K., Morton A.N., Rudland E., and Garland S.M. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis 194 (2006) 828-836